FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for escitalopram by Accord Healthcare Inc., finalizing a change to a generic escitalopram product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM)